These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 29522979

  • 1. High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial.
    Penna-Martinez M, Filmann N, Bogdanou D, Shoghi F, Huenecke S, Schubert R, Herrmann E, Koehl U, Husebye ES, Badenhoop K.
    Nutrition; 2018 May; 49():66-73. PubMed ID: 29522979
    [Abstract] [Full Text] [Related]

  • 2. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial.
    Meireles MS, Kamimura MA, Dalboni MA, Giffoni de Carvalho JT, Aoike DT, Cuppari L.
    Clin Nutr; 2016 Dec; 35(6):1251-1258. PubMed ID: 27161894
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D status and pathway genes in five European autoimmune Addison's disease cohorts.
    Penna-Martinez M, Meyer G, Wolff AB, Skinningsrud B, Betterle C, Falorni A, Ollier W, Undlien D, Husebye E, Pearce S, Mitchell AL, Badenhoop K.
    Eur J Endocrinol; 2021 Mar; 184(3):373-381. PubMed ID: 33444227
    [Abstract] [Full Text] [Related]

  • 4. Pilot Trial of Vitamin D3 and Calcifediol in Healthy Vitamin D Deficient Adults: Does It Change the Fecal Microbiome?
    Shieh A, Lee SM, Lagishetty V, Gottleib C, Jacobs JP, Adams JS.
    J Clin Endocrinol Metab; 2021 Nov 19; 106(12):3464-3476. PubMed ID: 34343292
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults.
    Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, Ziegler TR, Zughaier SM, Tangpricha V.
    Clin Nutr; 2017 Aug 19; 36(4):980-985. PubMed ID: 27402475
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D effects on monocytes' CCL-2, IL6 and CD14 transcription in Addison's disease and HLA susceptibility.
    Kraus AU, Penna-Martinez M, Meyer G, Badenhoop K.
    J Steroid Biochem Mol Biol; 2018 Mar 19; 177():53-58. PubMed ID: 28765037
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial.
    Giacomet V, Vigano A, Manfredini V, Cerini C, Bedogni G, Mora S, Borelli M, Trabattoni D, Zuccotti GV.
    HIV Clin Trials; 2013 Mar 19; 14(2):51-60. PubMed ID: 23611825
    [Abstract] [Full Text] [Related]

  • 12. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
    Fisk CM, Theobald HE, Sanders TA.
    J Nutr; 2012 Jul 19; 142(7):1286-90. PubMed ID: 22623396
    [Abstract] [Full Text] [Related]

  • 13. Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.
    Rovner AJ, Stallings VA, Rutstein R, Schall JI, Leonard MB, Zemel BS.
    Osteoporos Int; 2017 Jan 19; 28(1):201-209. PubMed ID: 27837268
    [Abstract] [Full Text] [Related]

  • 14. A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption.
    Charoenngam N, Kalajian TA, Shirvani A, Yoon GH, Desai S, McCarthy A, Apovian CM, Holick MF.
    Am J Clin Nutr; 2021 Sep 01; 114(3):1189-1199. PubMed ID: 34008842
    [Abstract] [Full Text] [Related]

  • 15. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.
    de Carvalho JTG, Schneider M, Cuppari L, Grabulosa CC, Cendoroglo M, Dalboni MA.
    J Ren Nutr; 2019 Sep 01; 29(5):454-461. PubMed ID: 30686751
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
    Simoneau T, Sawicki GS, Milliren CE, Feldman HA, Gordon CM.
    J Cyst Fibros; 2016 Mar 01; 15(2):234-41. PubMed ID: 26211605
    [Abstract] [Full Text] [Related]

  • 17. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P, Kiely PD.
    Scand J Rheumatol; 2009 Mar 01; 38(2):149-53. PubMed ID: 18991184
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial.
    Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, Mast DJ, Sanford PB, Sjoberg RJ.
    Endocr Pract; 2009 Apr 01; 15(3):203-12. PubMed ID: 19364687
    [Abstract] [Full Text] [Related]

  • 20. Low-Dose Vitamin D3 Supplementation Does Not Affect Natural Regulatory T Cell Population but Attenuates Seasonal Changes in T Cell-Produced IFN-γ: Results From the D-SIRe2 Randomized Controlled Trial.
    Maboshe W, Macdonald HM, Wassall H, Fraser WD, Tang JCY, Fielding S, Barker RN, Vickers MA, Ormerod A, Thies F.
    Front Immunol; 2021 Apr 01; 12():623087. PubMed ID: 34262557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.